首页> Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology> A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer.

A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer.

导出 OA

翻译打印收藏纠错

第一作者： Julia,Murray

第一单位： The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK.

作者： Julia,Murray ^[1] ; Clare,Griffin ^[2] ; Sarah,Gulliford ^[3] ; Isabel,Syndikus ^[4] ; John,Staffurth ^[5] ; Miguel,Panades ^[6] ; Christopher,Scrase ^[7] ; Chris,Parker ^[1] ; Vincent,Khoo ^[1] ; Jamie,Dean ^[2] ; Helen,Mayles ^[4] ; Philip,Mayles ^[4] ; Simon,Thomas ^[8] ; Olivia,Naismith ^[9] ; Angela,Baker ^[10] ; Helen,Mossop ^[2] ; Clare,Cruickshank ^[2] ; Emma,Hall ^[2] ; David,Dearnaley ^[11] ; CHHiP Investigators

作者单位： The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. ^[1] The Institute of Cancer Research, London, UK. ^[2] The Institute of Cancer Research, London, UK; Department of Radiotherapy, University College London Hospitals NHS Foundation Trust, UK. ^[3] Clatterbridge Cancer Centre, Wirral, UK. ^[4] Cardiff University/Velindre Cancer Centre, UK. ^[5] Lincoln County Hospital, UK. ^[6] Ipswich Hospital, UK. ^[7] Addenbrooke's Hospital, Cambridge, UK. ^[8] Royal Marsden NHS Foundation Trust, London, UK. ^[9] Royal Berkshire Hospital, Reading, UK. ^[10] The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: david.dearnaley@icr.ac.uk. ^[11]

关键词 Dosimetry Image-guided radiotherapy Prostate Toxicity